MYCN and neuroblastoma: Several analyses showed that the application of the BET inhibitor JQ1 downregulates N-Myc transcriptional signatures, lowering MYCN expression, thus increasing the survival percentage in both xenograft and transgenic murine models of NB (Figure 2) [100].